top of page
Kroger’s $24.6bn Acquisition of Albertsons
By Matilda Oculy and Filip Stoilov (University of Manchester), Sameer Jain and Micheal Akullo (Wharton School) Photo: No Revisions...
The MergerSight Group
Oct 31, 20225 min read
1,397 views
Amazon’s $3.9bn Acquisition of One Medical
By Jack Lee, Heather Leung and Terry Au-Yeung (HKUST), Sonia Andrzejuk, Argyro Charizona and Vlad Marcu (Bocconi) Photo: Hyttalo Souza...
The MergerSight Group
Oct 19, 20225 min read
2,068 views
Novartis’ spin-off of Sandoz business
By Sameer Jain (Wharton School), Eden Yang (London School of Economics) Photo: Freestocks (Unsplash) Overview of the deal Parent:...
The MergerSight Group
Sep 12, 20224 min read
599 views
Pfizer $11.6bn Acquisition of Biohaven
By Justin Leung, Jack Lee, Heather Leung, and Sissi Zeng (Hong Kong University of Science and Technology) Photo: Christina Victoria...
The MergerSight Group
Jun 12, 20224 min read
1,507 views
Stryker’s $3.09bn Acquisition of Vocera Communications
By Matilda Oculy, Aadit Jain, András Szabó, and Deimantė Chailenko (Manchester), Joshua Ooi, Ayushman Nath, Danissa Wan, Jack Wu, and...
The MergerSight Group
Jan 26, 20224 min read
694 views
Merck’s $11.5bn Acquisition of Acceleron Pharma
By Tudor Popescu and Bella Chen (University of Chicago), Ivan Chung, Justin Leung, and Ryan Chan (HKUST) Photo: Louis Reed (Unsplash)...
The MergerSight Group
Oct 13, 20215 min read
1,102 views
Sanofi’s Acquisition of Kymab
By Lorenzo Mirone, Riccardo Colombo, Federico de Rosa (Bocconi University) and Roshni Padhi, Winston Shum, Moh Jin Yin (Stanford...
The MergerSight Group
Mar 10, 20214 min read
518 views
Jazz Pharmaceuticals’ $7.2bn Acquisition of GW Pharmaceuticals
By Edvard Bruu and Hannah Ohlsson (Stockholm School of Economics), Isabelle Duerbeck and Tim Bamberger (King’s College London) Photo:...
The MergerSight Group
Feb 23, 20215 min read
794 views
Pharmaceutical M&A
By Gurneek Gill (UCL), Nihat Anwar (SSE), Mustafa Bayramli (Wharton) Photo: Myriam Zilles (Unsplash) I. Industry Background The...
The MergerSight Group
Feb 1, 20217 min read
485 views
AstraZeneca to acquire Alexion in $39bn deal
By Itai Almogy, Gaspard Baroudel, Raphael Berz (Yale University), and Nathan Walemba (Oxford University) Photo: Julia Koblitz (Unsplash)...
The MergerSight Group
Jan 12, 20214 min read
1,048 views
Illumina’s $8bn Acquisition of GRAIL
By Vinay Naik (University of Warwick), Roshni Padhi, Amarins Laanstra-Corn and Winston Shum (Stanford University) Overview of the deal...
The MergerSight Group
Oct 5, 20204 min read
1,023 views
Gilead Sciences Inc.’s $21bn Acquisition of Immunomedics
By Jinghan Jennifer, Sanjana Ramaswamy, William Zhang (St Andrews), Mariana Velasco, Anthony Borgese, Mustafa Bayramli, Susan Xiao & Zen...
The MergerSight Group
Sep 28, 20205 min read
1,653 views
Nestlé's $2.6 Billion Acquisition of Aimmune Therapeutics
By Edvard Bruu and Wilma Tillqvist (Stockholm School of Economics), Aman Singla, Akhil Anand Vajjhala and Siddharth Tripurani (New York...
The MergerSight Group
Sep 14, 20204 min read
1,206 views
Teladoc Health and Livongo Merger
By: AJ Tomas (University of Chicago), Demi Akinjide, Saihejpal Ailwadhi, Ben Fobel, Zac Greenberg (University of Bristol) Overview of the...
The MergerSight Group
Sep 5, 202010 min read
2,719 views
Mylan’s Merger with Pfizer’s Upjohn Unit
Pfizer’s UpJohn franchise is merging with Mylan- the troubled EpiPen manufacturer shrouded in price fixing controversies.
mergersight
Sep 7, 20197 min read
1,273 views
AbbVie’s $63 billion Acquisition of Allergan
US drugmaker AbbVie launched a $63 billion bid for Botox maker Allergan in what will result in the world’s fifth largest drug company.
mergersight
Jul 27, 20197 min read
1,645 views
Danaher $21.4bn acquisition of General Electric’s Life Sciences division
General Electric sold its Life Sciences division to Danaher Corporation for $21.4bn, as part of GE's plan to push further its aviation.
mergersight
Jun 15, 20195 min read
633 views
Roche’s $4.3 billion acquisition of Spark
Roche, the Swiss drugs group, has won a two-way race to acquire Spark Therapeutics, Inc. for $4.8bn.
The MergerSight Group
May 8, 20194 min read
577 views
Merck’s $2.4bn acquisition of Antelliq
Merck's strategic acquisition of Antelliq leads the path to sustainable and significant investments in agricultural technologies.
The MergerSight Group
Mar 13, 20194 min read
1,024 views
Eli Lilly’s $8bn Acquisition of Loxo Oncology
Eli Lilly’s most recent acquisition marks a clear strategic path towards immunotherapy and oncology for the firm.
The MergerSight Group
Mar 9, 20195 min read
570 views
bottom of page